A Aralex Aachen research explorer

September 11, 2023 article Open access

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial

The Lancet Oncology

DOI: 10.1016/s1470-2045(23)00396-0 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 4 stored of 136

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis
2026 The Lancet Oncology article Medicine Intraperitoneal and Appendiceal Malignancies

5

citations
Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellows
2026 International Journal of Gynecological Cancer article Medicine Endometrial and Cervical Cancer Treatments

0

citations
Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer
2026 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment Open access

0

citations
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank
2024 Annals of Diagnostic Pathology article Medicine Ovarian cancer diagnosis and treatment Open access

4

citations

4 results

References 0